198 related articles for article (PubMed ID: 27235787)
1. Human ex-vivo action potential model for pro-arrhythmia risk assessment.
Page G; Ratchada P; Miron Y; Steiner G; Ghetti A; Miller PE; Reynolds JA; Wang K; Greiter-Wilke A; Polonchuk L; Traebert M; Gintant GA; Abi-Gerges N
J Pharmacol Toxicol Methods; 2016; 81():183-95. PubMed ID: 27235787
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Comparison of Effects of Dofetilide, Sotalol, Quinidine, and Verapamil between Human
Britton OJ; Abi-Gerges N; Page G; Ghetti A; Miller PE; Rodriguez B
Front Physiol; 2017; 8():597. PubMed ID: 28868038
[No Abstract] [Full Text] [Related]
3. Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae.
Qu Y; Page G; Abi-Gerges N; Miller PE; Ghetti A; Vargas HM
Front Physiol; 2017; 8():1109. PubMed ID: 29354071
[TBL] [Abstract][Full Text] [Related]
4. Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs.
Valentin JP; Hoffmann P; De Clerck F; Hammond TG; Hondeghem L
J Pharmacol Toxicol Methods; 2004; 49(3):171-81. PubMed ID: 15172013
[TBL] [Abstract][Full Text] [Related]
5. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
Guérard NC; Traebert M; Suter W; Dumotier BM
J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
[TBL] [Abstract][Full Text] [Related]
6. Sophoridine manifests as a leading compound for anti-arrhythmia with multiple ion-channel blocking effects.
Song T; Hao Y; Wang M; Li T; Zhao C; Li J; Hou Y
Phytomedicine; 2023 Apr; 112():154688. PubMed ID: 36738478
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk.
Qu Y; Gao B; Arimura Z; Fang M; Vargas HM
Clin Transl Sci; 2021 Jul; 14(4):1600-1610. PubMed ID: 33955165
[TBL] [Abstract][Full Text] [Related]
8. Detection of proarrhythmia in the female rabbit heart: blinded validation.
Hondeghem LM; Lu HR; van Rossem K; De Clerck F
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):287-94. PubMed ID: 12716112
[TBL] [Abstract][Full Text] [Related]
9. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates.
Guo L; Dong Z; Guthrie H
J Pharmacol Toxicol Methods; 2009; 60(2):130-51. PubMed ID: 19616638
[TBL] [Abstract][Full Text] [Related]
10. Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential.
Abi-Gerges N; Valentin JP; Pollard CE
Br J Pharmacol; 2010 Jan; 159(1):77-92. PubMed ID: 19663882
[TBL] [Abstract][Full Text] [Related]
11. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
Hondeghem LM; Carlsson L; Duker G
Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
[TBL] [Abstract][Full Text] [Related]
12. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
13. Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.
Lu HR; Vlaminckx E; Gallacher DJ
J Pharmacol Toxicol Methods; 2008; 57(1):1-8. PubMed ID: 17964190
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of physiological late Na
El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
[TBL] [Abstract][Full Text] [Related]
15. Nonlinearity between action potential alternans and restitution, which both predict ventricular arrhythmic properties in Scn5a+/- and wild-type murine hearts.
Matthews GD; Guzadhur L; Grace A; Huang CL
J Appl Physiol (1985); 2012 Jun; 112(11):1847-63. PubMed ID: 22461438
[TBL] [Abstract][Full Text] [Related]
16. Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies.
Ligneau X; Shah RR; Berrebi-Bertrand I; Mirams GR; Robert P; Landais L; Maison-Blanche P; Faivre JF; Lecomte JM; Schwartz JC
Br J Pharmacol; 2017 Dec; 174(23):4449-4463. PubMed ID: 28941245
[TBL] [Abstract][Full Text] [Related]
17. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
[TBL] [Abstract][Full Text] [Related]
18. Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
Zhang X; Guo L; Zeng H; White SL; Furniss M; Balasubramanian B; Lis E; Lagrutta A; Sannajust F; Zhao LL; Xi B; Wang X; Davis M; Abassi YA
J Pharmacol Toxicol Methods; 2016; 81():201-16. PubMed ID: 27282640
[TBL] [Abstract][Full Text] [Related]
19. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
Osadchii OE
PLoS One; 2018; 13(1):e0191514. PubMed ID: 29352276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
